Annual Drug Patent Expirations for ALPHAGAN+P
Alphagan P is a drug marketed by Abbvie and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug and two Paragraph IV challenges.
Drug patent litigation for ALPHAGAN P.
The generic ingredient in ALPHAGAN P is brimonidine tartrate. Two suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
